Andrew Chatr-Aryamontri

3PUBLICATIONS
59CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Feb 09, 2026
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.

Jasmin Coulombe-Huntington, Thierry Bertomeu, Caroline Huard

|Jun 12, 2025
CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity.

Marcelo M Rodriguez, Debashree Chatterjee, Johanna Guerry

Pageof 1

Frequent Collaborators

2 joint publications

Thierry Bertomeu

2 joint publications

Sylvie Mader

1 joint publications

Marcelo M Rodriguez

1 joint publications

Anne-Marie Patenaude